Debut Biotechnology
Latest round
- Series B
Last raised
- Oct 2023
Total raised
- $95M
Investors
- 15
About Debut Biotechnology
Debut Biotechnology, Inc., founded in 2019 and headquartered in San Diego, US, specializes in delivering high-performance beauty solutions. In August 2025, Debut Biotechnology, Inc. The founder, Gregory Weiss, has a history of involvement in biotechnology ventures, while Joshua Britton serves as the CEO. Debut Biotechnology specializes in developing innovative, scientifically engineered beauty products that leverage advanced biotechnology. The company's core offerings consist of novel, bio-based ingredients that promise heightened performance and functionality in various beauty applications. These ingredients have been clinically tested and are positioned to meet the needs of forward-thinking beauty brands aiming to enhance consumer experiences. Debut's client base includes major beauty brands across North America and Europe, where their products are utilized in skincare, haircare, and cosmetic formulations.Debut Biotechnology generates revenue primarily through partnerships with beauty brands and direct sales of its proprietary ingredients. The business model emphasizes B2B transactions, where beauty brands integrate Debut's ingredients into their product lines. This collaboration often involves long-term partnerships, wherein brands may subscribe to receive continuous access to Debut's innovative ingredients and formulations. While specific pricing plans are not disclosed, the company's transactions are structured around negotiated agreements that reflect the unique value proposition of Debut's flagship products.
Who invested in Debut Biotechnology
15 investors across 5 rounds
See all investors in Debut Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Debut Biotechnology
Who invested in Debut Biotechnology?
Debut Biotechnology has 15 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Debut Biotechnology raised?
Debut Biotechnology has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Debut Biotechnology last raise money?
Debut Biotechnology's most recent round on record is a Series B, in Oct 2023.
What does Debut Biotechnology do?
Debut Biotechnology is a biotechnology company.
Where is Debut Biotechnology headquartered?
Debut Biotechnology is headquartered in San Diego, US.
Which VCs invest in companies like Debut Biotechnology?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Debut Biotechnology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Debut Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.